Clinical Trial Update: Inhaled Nitric Oxide in Pulmonary Embolism [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating inhaled nitric oxide for pulmonary embolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Medical University of Vienna | Conditions: Pulmonary Embolism | Phase 2 | Status: COMPLETED